BRETYLIUM TOSYLATE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Bretylium Tosylate, and what generic alternatives are available?
Bretylium Tosylate is a drug marketed by Abraxis Pharm, Astrazeneca, Breckenridge, Hikma, Hospira, Intl Medication, Luitpold, Abbott, B Braun, Baxter Hlthcare, and Hospira Inc. and is included in sixteen NDAs.
The generic ingredient in BRETYLIUM TOSYLATE is bretylium tosylate. There are three drug master file entries for this compound. Additional details are available on the bretylium tosylate profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for BRETYLIUM TOSYLATE?
- What are the global sales for BRETYLIUM TOSYLATE?
- What is Average Wholesale Price for BRETYLIUM TOSYLATE?
Summary for BRETYLIUM TOSYLATE
US Patents: | 0 |
Applicants: | 11 |
NDAs: | 16 |
Raw Ingredient (Bulk) Api Vendors: | 80 |
Patent Applications: | 1,359 |
DailyMed Link: | BRETYLIUM TOSYLATE at DailyMed |